Global Information
회사소개 | 문의 | 위시리스트

세계의 DTC(Direct-to-Consumer) 유전자 검사 시장(2019-2023년)

Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2019년 08월 상품 코드 909622
페이지 정보 영문 123 Pages
가격
US $ 2,500 ₩ 3,017,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,621,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,828,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 6,035,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 DTC(Direct-to-Consumer) 유전자 검사 시장(2019-2023년) Direct-to-consumer Genetic Testing Market by Distribution Channel, Service, and Geography - Global Forecast and Analysis 2019-2023
발행일 : 2019년 08월 페이지 정보 : 영문 123 Pages

세계 DTC(Direct-to-Consumer) 유전자 검사 시장은 조기 질환 진단에서의 DTC 유전자 검사 채용 증가, 가처분 소득 증가, DTC 유전자 검사 키트의 규제 당국 승인 증가 등이 성장 촉진요인이 되어 예측기간 중 16% 이상의 연평균 복합 성장률(CAGR)로 확대될 전망입니다. 하지만, 분석 및 임상적 타당성에 대한 의문, 한정적인 상환 정책, 개인 데이터의 안전성과 프라이버시에 관한 우려 등의 요인이 얘측기간 중 DTC 유전자 검사 시장의 성장을 방해할 가능성이 있습니다.

세계의 DTC(Direct-to-Consumer) 유전자 검사 시장에 대해 조사 분석했으며, 시장 규모 및 성장률, 시장 동향, 시장 성장 촉진요인과 과제, 시장 기회 분석, 주요 벤더 등에 대한 체계적인 정보를 제공합니다.

목차

제1장 주요 요약

제2장 조사 범위

  • 서론 1
  • 서론 2
  • 달러의 통화 환산율

제3장 시장 상황

  • 시장 생태계
  • 시장의 특징
  • 시장 세분화 분석

제4장 시장 규모

  • 시장 정의
  • 시장 규모(2018년)
  • 시장 규모 및 예측(2018-2023년)

제5장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 현황

제6장 시장 세분화 : 유통채널별

  • 시장 세분화 : 유통채널별
  • 유통채널별 비교 : 시장 규모 및 예측(2018-2023년)
  • 직접 판매
  • 소매 판매
  • 시장 기회 : 유통채널별

제7장 고객 상황

제8장 시장 세분화 : 서비스별

  • 시장 세분화 : 서비스별

제9장 지역별 상황

  • 지역별 세분화
  • 지역별 비교 : 시장 규모 및 예측(2018-2023년)
  • 북미
  • 유럽
  • 아시아
  • 기타 지역
  • 주요 국가
  • 시장 기회

제10장 성장 촉진요인과 과제

  • 시장 성장 촉진요인
  • 시장의 과제

제11장 시장 동향

  • 차세대 유전자 배열 결정의 진보
  • 서비스 비용 하락
  • 온라인 서비스 플랫폼 채용 증가

제12장 벤더 상황

  • 개요
  • 파괴적 혁신

제13장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • 23andMe Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.

제14장 부록

  • 조사 방법
  • 약어 리스트
  • 벤더의 시장 포지셔닝 정의

제15장 TECHNAVIO에 대해

LSH 19.09.09

About this market

Technavio's direct-to-consumer genetic testing market analysis considers sales from both direct sales and retail sales. Our analysis also considers the sales of direct-to-consumer genetic testing in Asia, Europe, North America, and ROW. In 2018, the direct sales segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as a reduction in additional costs involved in distribution and logistics will play a significant role in the direct sales segment to maintain its market position. Also, our global direct-to-consumer genetic testing market report looks at factors such as growing adoption of direct-to-consumer genetic testing in early disease diagnosis, rising disposable income, and increasing regulatory approvals of direct-to-consumer genetic testing kits. However, doubts over-analytical and clinical validity, limited reimbursement policies, and concerns over safety and privacy of personal data may hamper the growth of the direct-to-consumer genetic testing industry over the forecast period.

Overview

Growing adoption of direct-to-consumer genetic testing in early disease diagnosis

The adoption of direct-to-consumer genetic testing has increased, especially among people with a family history of certain diseases with a greater chance of their genetic transmission to their progeny. The increasing number of people with Alzheimer, cancer, and Parkinson's disease has fueled the demand for these tests. Direct-to-consumer genetic testing kit helps in the early diagnosis of diseases and help approach physicians for further monitoring and prevention. This will lead to the expansion of the global direct-to-consumer genetic testing market at a CAGR of over 16% during the forecast period.

Growing adoption of online service platforms

The increase in the adoption of digital trends in the healthcare industry has enabled vendors to have the edge over their competitors by offering better healthcare services. Online ordering facilities has increased the propensity of the consumers to avail more direct-to-consumer genetic tests. This leads the companies to provide attractive discounts to promote sales through online platforms. The availability of a digital database of consumers helps companies to analyze the performance of their products and improve through constant development and upgrades. This adoption of online service platforms is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global direct-to-consumer genetic testing market during the forecast period 2019-2023, view our report.

Competitive Landscape

With the presence of several major players, the global direct-to-consumer genetic testing market is moderately fragmented. Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading direct-to-consumer genetic testing manufacturers, that include 23andMe Inc., Invitae Corp., Laboratory Corp. of America Holdings, Myriad Genetics Inc., Quest Diagnostics Inc.

Also, the direct-to-consumer genetic testing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

TABLE OF CONTENTS

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • 2.1 Preface
  • 2.2 Preface
  • 2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY DISTRIBUTION CHANNEL

  • Market segmentation by distribution channel
  • Comparison by distribution channel
  • Direct sales - Market size and forecast 2018-2023
  • Retail sales - Market size and forecast 2018-2023
  • Market opportunity by distribution channel

PART 07: CUSTOMER LANDSCAPE

PART 08: MARKET SEGMENTATION BY SERVICE

  • Market segmentation by service

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 11: MARKET TRENDS

  • Advances in next-generation genetic sequencing
  • Reduction in the cost of services
  • Growing adoption of online service platforms

PART 12: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 13: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • 23andMe Inc.
  • Invitae Corp.
  • Laboratory Corp. of America Holdings
  • Myriad Genetics Inc.
  • Quest Diagnostics Inc.

PART 14: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 15: EXPLORE TECHNAVIO

LIST OF EXHIBITS:

  • Exhibit 01: Product overview
  • Exhibit 02: Global healthcare market
  • Exhibit 03: Segments of global healthcare market
  • Exhibit 04: Market characteristics
  • Exhibit 05: Market segments
  • Exhibit 06: Market definition - Inclusions and exclusions checklist
  • Exhibit 07: Market size 2018
  • Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
  • Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
  • Exhibit 10: Five forces analysis 2018
  • Exhibit 11: Five forces analysis 2023
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2018
  • Exhibit 18: Distribution channel - Market share 2018-2023 (%)
  • Exhibit 19: Comparison by distribution channel
  • Exhibit 20: Direct sales - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 21: Direct sales - Year-over-year growth 2019-2023 (%)
  • Exhibit 22: Retail sales - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 23: Retail sales - Year-over-year growth 2019-2023 (%)
  • Exhibit 24: Market opportunity by distribution channel
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global direct-to-consumer genetic testing market: Segmentation by service 2018 (%)
  • Exhibit 27: Market share by geography 2018-2023 (%)
  • Exhibit 28: Geographic comparison
  • Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
  • Exhibit 31: Europe - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 32: Europe - Year-over-year growth 2019-2023 (%)
  • Exhibit 33: Asia - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 34: Asia - Year-over-year growth 2019-2023 (%)
  • Exhibit 35: ROW - Market size and forecast 2018-2023 ($ millions)
  • Exhibit 36: ROW - Year-over-year growth 2019-2023 (%)
  • Exhibit 37: Key leading countries
  • Exhibit 38: Market opportunity
  • Exhibit 39: Impact of drivers and challenges
  • Exhibit 40: Vendor landscape
  • Exhibit 41: Landscape disruption
  • Exhibit 42: Vendors covered
  • Exhibit 43: Vendor classification
  • Exhibit 44: Market positioning of vendors
  • Exhibit 45: 23 andMe Inc. - Vendor overview
  • Exhibit 46: 23 andMe Inc. - Business segments
  • Exhibit 47: 23 andMe Inc. - Organizational developments
  • Exhibit 48: 23 andMe Inc. - Key offerings
  • Exhibit 49: Invitae Corp. - Vendor overview
  • Exhibit 50: Invitae Corp. - Business segments
  • Exhibit 51: Invitae Corp. - Organizational developments
  • Exhibit 52: Invitae Corp. - Geographic focus
  • Exhibit 53: Invitae Corp. - Key offerings
  • Exhibit 54: Laboratory Corp. of America Holdings - Vendor overview
  • Exhibit 55: Laboratory Corp. of America Holdings - Business segments
  • Exhibit 56: Laboratory Corp. of America Holdings - Organizational developments
  • Exhibit 57: Laboratory Corp. of America Holdings - Geographic focus
  • Exhibit 58: Laboratory Corp. of America Holdings - Segment focus
  • Exhibit 59: Laboratory Corp. of America Holdings - Key offerings
  • Exhibit 60: Myriad Genetics Inc. - Vendor overview
  • Exhibit 61: Myriad Genetics Inc. - Business segments
  • Exhibit 62: Myriad Genetics Inc. - Organizational developments
  • Exhibit 63: Myriad Genetics Inc. - Segment focus
  • Exhibit 64: Myriad Genetics Inc. - Key offerings
  • Exhibit 65: Quest Diagnostics Inc. - Vendor overview
  • Exhibit 66: Quest Diagnostics Inc. - Business segments
  • Exhibit 67: Quest Diagnostics Inc. - Organizational developments
  • Exhibit 68: Quest Diagnostics Inc. - Geographic focus
  • Exhibit 69: Quest Diagnostics Inc. - Segment focus
  • Exhibit 70: Quest Diagnostics Inc. - Key offerings
  • Exhibit 71: Validation techniques employed for market sizing
  • Exhibit 72: Definition of market positioning of vendors
Back to Top
전화 문의
F A Q